Next Sequence

Zafrens exists at the confluence of engineering, biology, chemistry and informatics to study cells as comprehensively as possible. We map the molecular states of millions of cells at a time to their individual functional manifestations. In doing so we begin to understand the regulatory layers of the cell (how molecular state is converted to function), which, so far has remained challenging to study.

Alex Felman is a veteran of the family office community for almost a decade; working as managing director with his own family office, Felman Family Office, on the ground with local families in Brazil, China, Denmark and South Korea and remotely with other family offices around the globe.

He uses his expertise in Molecular Toxicology andBio-entrepreneurship(B.A from University of California -Berkeley, MBA from Copenhagen Business School) to advise them in biotechnology, healthcare, and other futuristic tech industries with the goal of maintaining long-term wealth through innovation.

He is personally involved with a number of early-stage companies having previously worked as a general partner of Venture Labs, an early stage venture capital/ incubator fund as well as a mentor, advisor, serial entrepreneur and director of numerous startups. Alex is an expert in helping companies with business plan creation, product development, operations, successful market launches, and fundraising.

Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking high-throughput single cell analyses to clinical research, diagnostics and drug development. 500+ single-cell sequencing experts around the world are working together to translate advanced and proprietary multi-omics single-cell technologies into products that can be easily deployed in any lab and provide improved research results faster than ever before.

Arctoris is a tech-enabled drug discovery company headquartered in Oxford and Boston. Arctoris combines its unique automation platform, Ulysses, with advanced computational approaches and a world-class team of seasoned drug hunters to guide and rapidly progress its wholly owned and partnered drug discovery programs in oncology and neurology.

With open data and AI, Materiom empowers scientists, material developers, and brands to accelerate R&D and drive massive market entry. Materiom platform gathers the world of regenerative material solutions to optimize and match them to real-world needs.

Infinimmune’s founding team are tool builders who design from first principles and have broad expertise across immunology, single cell technologies, protein engineering, computational biology, and genome assembly.Transforming human antibodies into drugs.

We believe that everyone should be able to make easy choices they know are sustainable and healthy.

We are reimagining farming by blending the natural process of fermentation with modern science and technology, in order to make everyday essentials.

We just happen to make a great alternative to palm oil.

Investing on behalf of a group of ultra successful entrepreneurs, Talis Capital backs visionary founders at Seed and Serie A. Talis invests with high conviction at Seed & Series A across Europe and US and help founders build category defining companies such as Darktrace, Onfido, Ynsect, Pricefx, Seqera Labs, PortalOne, Howl

Discussing about Policy for the Bioeconomy in Africa including:

-World Organisation for Animal Health: A global authority on animal health: we work to ensure the health of animals & their environments across the world, recognising that animal health impacts everyone’s health & that the safety of our future depends on it.

- Bioeconomy Coalition of Africa: A platform of stakeholders working together to grow the bioeconomy in Africa. The platform is hosted by Science Foundation for Livelihoods and Development.

BioLinker is a  biotechnology company that using synthetic biology to provide kits for the synthesis of cell-free recombinant proteins, in addition to solutions and services for the production and purification of recombinant proteins in several systems.